Navigation Links
Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib

Indian Pharmaceuticals companies Glenmark pharma and Nicholas Piramal has withdrawn their drug Valdecoxib from the Indian market after USFDA ban the sale of Valdecoxib formulation products and the recent notification issued by // the health ministry of the government of India asking the pharma companies to stop selling and production of Valdecoxib. Ranbaxy as already withdrew the drug from the market after the suggestions of the National Pharmacological vigilance Advisory Committee.

Glenmark Pharma had a major market share in this drug Valdecoxib was at Rs. 25 crores, which subsequently dropped to around Rs. 12 crores, whereas Nicholas had about Rupees 12 crores. Mr. A.S. Mohanty of Glenmark said, “The Indian market abides by the norms laid down by the Drugs Controller General of India. The drug control had advised us to discontinue the manufacture and sale of Valdecoxib in India recently. We had stopped producing and marketing formulations containing Valdecoxib in India. We have recalled all the existing stocks from the market”. Glenmark has plans of replacing Valdecoxib with other alternate molecules for treatment of pain relief. He said, “Our pain management portfolio has several other brands based on molecules such as Etoricoxib and Aceclofenac, which are being promoted to replace Valdecoxib.
'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2019)... N.Y. (PRWEB) , ... June 20, 2019 , ... ... and a portfolio company of Chicago Pacific Founders, announced a strategic partnership with ... The partnership expands SightMD’s leading position in New York, adding the Company’s ...
(Date:6/19/2019)... , ... June 19, 2019 , ... CEO Steven C. ... Top CEOs in 2019 . Glassdoor , one of the world’s ... highlights top leaders employees love working for in countries throughout North America and parts ...
(Date:6/19/2019)... ... June 19, 2019 , ... LifeLearn Animal Health launches PetInsuranceInfo.com, ... insurance is, what it isn’t, and the questions they need to ask prior to ... different pet insurance companies and find the coverage that meets their budget and pet’s ...
(Date:6/18/2019)... ... June 18, 2019 , ... ... needs in the field of urology, today announced that Aaron Berger, MD, Associated ... of Excellence. The designation recognizes that Dr. Aaron Berger has achieved a high ...
(Date:6/16/2019)... PETERSBURG, Fla. (PRWEB) , ... June 16, 2019 ... ... interview of the MMJ International Holdings executives focusing on scientific research for the advancement ... 2019 @ 1:30p.m. on CNBC. Check your local listings for more information. , With ...
Breaking Medicine News(10 mins):
(Date:6/24/2019)... ... June 24, 2019 , ... ... provide breathability and comfort for the electrical industry has today announced the release ... , The guide, titled Developing a Culture of Electrical Safety, is written ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... dust from the World Trade Center site had activated chronic inflammation in their ... Mount Sinai researchers in Molecular Cancer Research in June. , Inflammation has ...
(Date:6/20/2019)... ... June 20, 2019 , ... ERT, a global data and ... scientific and technological experts will present a series of innovative and educational live ... in San Diego, June 23-27. , ERT’s industry-recognized thought leaders will share ...
Breaking Medicine Technology: